Some of the most common antibiotics and anticancer drugs block topoisomerases that snip the tangles out of DNA. If a cell cannot remove the tangles, it dies. Researchers investigating the structure of these enzymes have found that Type II topoisomerases, which snip double-stranded DNA, use their metal catalysts in a novel way that could help drug designers improve antimicrobials and cancer poisons and make them less toxic to the host.